13 August 2024
Latham & Watkins Advises scPharmaceuticals on Growth Financings
Advising firms
Deal team
14 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Haim Zaltzman Lead | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Dan Van Fleet Lead | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Erin Cusenbary | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Tony Noh | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Ian Drazen | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Kirt Switzer | Latham & Watkins LLP | Partner | tax | Not stated |
| Gregory Conyers | Latham & Watkins LLP | Associate | tax | Not stated |
| Jekkie Kim | Latham & Watkins LLP | Partner | healthcare and life sciences | Not stated |
| Mizuna Sekine | Latham & Watkins LLP | Associate | healthcare and life sciences | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | healthcare and life sciences | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | FDA regulatory | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA regulatory | Not stated |
| Josh Friedman | Latham & Watkins LLP | Partner | ERISA | Not stated |
| Wesley Holmes | Latham & Watkins LLP | Partner | corporate | Not stated |
Stated terms
- Stated value
- USD 125m (US$125 million)
- What the figure measures
- Facility amount
- Client
- scPharmaceuticals Inc.Borrower
- Counterparties
- Perceptive Advisors (Lenders)